WEBINAR ARCHIVE: 11 MARKET ACCESS QUESTIONS TO ADDRESS PRIOR TO LAUNCHING YOUR FIRST SPECIALTY DRUG
Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. As manufacturers prepare for launch, they must sort through and choose third-party organizations that can help support their efforts: 3PL organizations, distribution partners, pharmacies, HUB providers, serialization partners, data analytics, and more. Getting answers to these eleven key questions will help guide commercial teams in effectively launching specialty products.
Key Learning Objectives
Identify the types of third-party organizations that can help support your specialty drug launch
Understand the key considerations and composition of establishing third-party partnerships
Determine the difference between having greater access or greater control, and how that can impact the commercial success of your launch
This webinar was presented live on October 5, 2022.
Read more on this topic on our blog.